<DOC>
	<DOCNO>NCT02822963</DOCNO>
	<brief_summary>Benign prostatic hyperplasia ( BPH ) common disease urology among old men . If BPH symptom control drug , transurethral resection prostate ( TURP ) , recommend . Although procedure quit safe , old men often take anticoagulant antiplatelets control cardiovascular disease , arose concern bleed risk . The management anticoagulation patient undergoing surgical procedure challenge interrupt anticoagulation increase risk thrombotic event . At time , surgery invasive procedure associate bleed risk increase anticoagulant administration . Now , recommendation anticoagulant antiplatelets discontinuation concrete evidence , especially TURP . Furthermore , relative study do Taiwan population , call investigation .</brief_summary>
	<brief_title>Impact Anticoagulants Antiplatelets Patients Transurethral Resection Prostate</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>Admitted National Cheng Kung University Hospital Urology study Older 20 year old Agree participate study Receiving transurethral resection prostate benign prostatic hyperplasia prostate cancer Poor expression ability without close care giver answer question</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Transurethral resection prostate</keyword>
	<keyword>Anticoagulants</keyword>
	<keyword>Platelet aggregation inhibitor</keyword>
</DOC>